Detalhe da pesquisa
1.
CDK7-dependent transcriptional addiction in triple-negative breast cancer.
Cell
; 163(1): 174-86, 2015 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26406377
2.
A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis.
Cell
; 137(6): 1032-46, 2009 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-19524507
3.
The p110α and p110ß isoforms of PI3K play divergent roles in mammary gland development and tumorigenesis.
Genes Dev
; 26(14): 1573-86, 2012 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22802530
4.
X chromosomal abnormalities in basal-like human breast cancer.
Cancer Cell
; 9(2): 121-32, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16473279
5.
A role for the scaffolding adapter GAB2 in breast cancer.
Nat Med
; 12(1): 114-21, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16369543
6.
Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts.
Proc Natl Acad Sci U S A
; 107(46): 20009-14, 2010 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-21041659
7.
Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers.
Breast Cancer Res
; 12(6): R95, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21080930
8.
The CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition.
Clin Cancer Res
; 25(20): 6127-6140, 2019 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31409614
9.
Loss of heterozygosity and its correlation with expression profiles in subclasses of invasive breast cancers.
Cancer Res
; 64(1): 64-71, 2004 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14729609
10.
Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases.
Nat Med
; 22(7): 723-6, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27270588
11.
Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs.
Biomark Res
; 3: 9, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26015868
12.
RelA-Induced Interferon Response Negatively Regulates Proliferation.
PLoS One
; 10(10): e0140243, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26460486
13.
Molecular characterization of the HLA-Cw*0409N allele.
Hum Immunol
; 63(4): 295-300, 2002 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12039411
14.
Tumor mutation burden forecasts outcome in ovarian cancer with BRCA1 or BRCA2 mutations.
PLoS One
; 8(11): e80023, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24265793
15.
Profiles of genomic instability in high-grade serous ovarian cancer predict treatment outcome.
Clin Cancer Res
; 18(20): 5806-15, 2012 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22912389
16.
Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agents.
Cancer Discov
; 2(4): 366-375, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22576213
17.
Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer.
J Clin Oncol
; 28(7): 1145-53, 2010 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20100965
18.
Genomic approaches in cancer biology.
Surgery
; 136(3): 511-8, 2004 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15349094
19.
SIK1 couples LKB1 to p53-dependent anoikis and suppresses metastasis.
Sci Signal
; 2(80): ra35, 2009 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-19622832
20.
Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling.
Cancer Cell
; 16(2): 115-25, 2009 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-19647222